Indication
Yellow fever vaccination
Yellow fever vaccination is an active immunization procedure indicated for the prevention of yellow fever virus infection, an acute mosquito-borne flavivirus disease endemic to tropical regions of sub-Saharan Africa and parts of South America. Read more about Yellow fever vaccination
4 drugs 1 manufacturers
Drugs that treat it
Common Yellow fever vaccination therapies.
STAMARIL (yellow fever vaccine live/PF)
YF-VAX (PF) (yellow fever vaccine live/PF)
STAMARIL (PF) (yellow fever vaccine live/PF)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonYellow fever vaccination is an active immunization procedure indicated for the prevention of yellow fever virus infection, an acute mosquito-borne flavivirus disease endemic to tropical regions of sub-Saharan Africa and parts of South America.
It is primarily indicated for persons aged 9 months and older who reside in, travel to, or handle viral specimens in high-risk areas, as well as to fulfill international travel health entry regulations.
The target condition ranges clinically from an acute, self-limiting febrile syndrome to severe pansystemic dysfunction characterized by hepatic injury with jaundice, coagulopathy with mucosal hemorrhage, renal failure, and cardiovascular collapse.
The clinical state addressed by this prophylactic indication is systemic susceptibility to infection, aiming to elicit protective neutralizing antibodies prior to potential exposure.
- cdc.gov
Yellow fever vaccination is an active immunization procedure indicated for the prevention of yellow fever virus infection, an acute mosquito-borne flavivirus disease endemic to tropical regions of sub-Saharan Africa and parts of South America It is primarily indicated for persons aged 9 months and older who reside in, travel to, or handle viral specimens in high-risk areas, as well as to fulfill international travel health entry regulations
- fda.gov
Yellow fever vaccination is an active immunization procedure indicated for the prevention of yellow fever virus infection, an acute mosquito-borne flavivirus disease endemic to tropical regions of sub-Saharan Africa and parts of South America The target condition ranges clinically from an acute, self-limiting febrile syndrome to severe pansystemic dysfunction characterized by hepatic injury with jaundice, coagulopathy with mucosal hemorrhage, renal failure, and cardiovascular collapse The clinic...
- cdc.gov
It is primarily indicated for persons aged 9 months and older who reside in, travel to, or handle viral specimens in high-risk areas, as well as to fulfill international travel health entry regulations The target condition ranges clinically from an acute, self-limiting febrile syndrome to severe pansystemic dysfunction characterized by hepatic injury with jaundice, coagulopathy with mucosal hemorrhage, renal failure, and cardiovascular collapse
- goodrx.com
The clinical state addressed by this prophylactic indication is systemic susceptibility to infection, aiming to elicit protective neutralizing antibodies prior to potential exposure
Personalize your experience
Follow Yellow fever vaccination and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.